Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2005
06/22/2005EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors
06/22/2005EP1542675A1 Compounds useful for the inhibition of aldh
06/22/2005EP1282619B1 Processes for the preparation of thiazolidinedione derivatives and intermediates
06/22/2005EP1268466B1 Decahydro-isoquinolines
06/22/2005EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630637A Novel arylheteroalkylamine derivatives
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1629283A Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/22/2005CN1207283C 4-aminopiperidine derivatives and their use as medicine
06/21/2005US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors
06/21/2005US6908939 Biaromatic ligand activators of PPARγ receptors
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908937 Heterocyclic fluoroalkenyl thioethers (II)
06/21/2005US6908922 Linear cyclic ureas
06/21/2005US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
06/21/2005US6908884 For agriculture/horticulture/crops
06/21/2005CA2309473C New 4-arylpiperidine derivatives for the treatment of pruritus
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/16/2005WO2005054430A2 Hepatitis c virus inhibitors
06/16/2005WO2005054235A1 Process for the preparing ziprasidone monohydrochloride hydrate
06/16/2005WO2005054229A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics
06/16/2005WO2005054215A1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
06/16/2005WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor
06/16/2005WO2005054193A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
06/16/2005WO2005054186A2 Methods for the preparation of stereoisomerically enriched amines
06/16/2005WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005WO2005016326A3 Analogs of thalidomide as potential angiogenesis inhibitors
06/16/2005WO2004058753A8 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
06/16/2005WO2004046107A8 Indole derivatives as somatostatin agonists or antagonists
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
06/16/2005US20050131017 HIV protease inhibiting compounds
06/16/2005US20050131016 Chemical compounds
06/16/2005US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents
06/16/2005US20050131002 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents
06/16/2005US20050131001 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130997 Pyrimidinone viral polymerase inhibitors
06/16/2005US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects
06/16/2005US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer
06/16/2005US20050130981 Compounds
06/16/2005US20050130977 Inhibitors of akt activity
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130974 Benzothiazole compositions and their use as ubiquitin ligase inhibitors
06/16/2005US20050130970 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
06/16/2005US20050130967 3-Substituted-4-pyrimidone derivatives
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130962 Seratonin receptor antagonist; central nervous system disorders; halo phenyl substituents
06/16/2005US20050130959 Selective in presence of at least one other cathepsin isozyme; such as (3-cyclopentyl-{[5-(3-fluoro-phenyl)-furan-2-carbonyl]-amino}-propionylamino)-4-oxo-butyric acid
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130940 Fungal infections; water soluble phosphate derivatives of triazole drugs such as fluconazole
06/16/2005US20050130913 Synergistic insecticidal mixtures
06/16/2005US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening
06/16/2005US20050129623 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections
06/16/2005DE10351744A1 Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel Thiazolidinones, to their preparation and use as medicaments
06/16/2005CA2549289A1 Methods for the preparation of stereoisomerically enriched amines
06/16/2005CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005CA2549119A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2545582A1 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
06/15/2005EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539747A1 N-aroyl cyclic amines as orexin receptor antagonists
06/15/2005EP1539746A1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539733A2 Azabicyclic compounds are central nervous system active agents
06/15/2005EP1539725A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
06/15/2005EP1539724A1 Amino benzothiazole compounds with nos inhibitory activity
06/15/2005EP1539723A1 Novel use of benzothiazole derivatives
06/15/2005EP1539722A1 Thiazole derivatives
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity
06/15/2005EP1539710A1 Heterocyclic derivatives
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539700A1 8-hydroxy quinoline derivatives
06/15/2005EP1539178A2 Protease inhibitors
06/15/2005EP1539175A2 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
06/15/2005EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
06/15/2005EP1539151A1 Biaryl compounds having anti-infective activity
06/15/2005EP1539141A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
06/15/2005EP1349856B1 Isoindolin-1-one glucokinase activators
06/15/2005EP1311504B1 Tetrazolyl-phenyl acetamide glucokinase activators
06/15/2005EP1305301B1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
06/15/2005EP1140915B1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
06/15/2005EP1126843A4 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
06/15/2005EP1048658B1 Alicyclic acylated heterocyclic derivatives
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005CN1628114A Coumarines useful as biomarkers
06/15/2005CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1626532A Amide compounds
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 628